Breakthrough Starshot focuses on a tiny design with gigantic solar "wings" that would allow them to ride a beam of light to Alpha Centauri. However, for practical purposes, a probe that small will ...

Opening in 2025, Nusano’s state of the art radioisotope production facility in the Salt Lake City region of Utah will operate an alpha beam with a current 10-times greater than all the world’s ...

Green Alpha Advisors LLC’s holdings in Beam Therapeutics were worth $253,000 as of its most recent filing with the Securities and Exchange Commission. Other institutional investors also recently ...

Over 40 adult patients have enrolled in the BEACON trial for BEAM-101, a gene therapy expected to dose 30 patients by mid-2025. Additional trials for conditions like alpha-1 antitrypsin deficiency ...